Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history.

  title={Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history.},
  author={L. Bren},
  journal={FDA consumer},
  volume={35 2},
  • L. Bren
  • Published 2001
  • Medicine
  • FDA consumer
It was early 1942 and war was raging in the jungles of the Pacific. In addition to fighting the Japanese, Allied troops found themselves under attack by malaria-carrying mosquitoes. The search was on for an effective quinine substitute to combat the disease. A possible treatment-in the form of a dark, inky substance--arrived for testing in the pharmacology department at the University of Chicago. Pharmacologist Frances Oldham Kelsey, like many other university researchers throughout the country… Expand
36 Citations
Thalidomide â An Overview and the Species-Specific Teratogenicity
  • Highly Influenced
New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin.
  • 23
Good clinical practice (GCP): A universal call for ethics in biomedical research
  • PDF
Metformin in chronic kidney disease: more harm than help?
  • 12